The 21st Century Cures Act, passed in December, contains provisions that many have questioned and criticized. This review of those provisions shows that progress in this sector is being made.
Michele Russell-Einhorn, JD
Advertisement
Articles by Michele Russell-Einhorn, JD
Advertisement
Latest Updated Articles
No-Brainer Provisions of the 21st Century Cures ActJanuary 25th 2017
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: YPrime's Paulo Limgenco on Moving ESG From Reporting to Real Business Value
2
ACT Brief: Data Pipeline Standardization for Real-Time Analysis, Sponsor Accountability Beyond Contracts, and Autoimmune Pipeline Expansion
3
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
4
ACT Brief: Data Readiness Gap in Continuous Monitoring, Workflow-Centric AI Deployment, and First-in-Class ADHD Mechanism
5